Study S002703

'Managing Pasireotide-associated Hyperglycaemia in Acromegaly With Eucaloric Very-low Carbohydrate Ketogenic Diet Versus Diabetes Medication: a Multicentre, Randomized, Open-label Proof-of-concept Study'

ClinicalTrials.gov record

Registration

Registration: NCT07866846
Acronym: PasiAcroKeto
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: RECRUITING
Enrollment: 30
Start: 2025-07-29
Primary completion: 2027-12-31
Lead sponsor: Leiden University Medical Center
Conditions: Acromegaly Due to Pituitary Adenoma; Hyperglycemia; Ketogenic Diet; Standard Care Control
Interventions: DIETARY_SUPPLEMENT:Ketogenic diet; DRUG:Diabetes Medication
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Hemoglobin A1c (HbA1c) level [At baseline, and 3 months, 7 months, 9, 11 and 13 months after initiation of pasireotide treatment.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.